Humana (NYSE:HUM) Stock Rating Upgraded by Cantor Fitzgerald

Key Points

• Cantor Fitzgerald upgraded Humana from “neutral” to “overweight” and raised its price target from $300 to $460, implying 13.24% upside from the prior close.
• Humana reported quarterly EPS of $7.61, beating estimates of $7.27, while revenue rose 26.2% year over year to $40.89 billion.
• Analyst sentiment is broadly positive, with 16 buy ratings, 13 holds and one sell rating, resulting in a “Moderate Buy” consensus and an average price target of $415.57.

Humana (NYSE:HUM - Get Free Report) was upgraded by investment analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating in a note issued to investors on Wednesday, MarketBeat reports. The firm currently has a $460.00 price objective on the insurance provider's stock, up from their previous price objective of $300.00. Cantor Fitzgerald's price target suggests a potential upside of 13.24% from the company's previous close.

HUM has been the subject of a number of other research reports. Royal Bank Of Canada raised their target price on shares of Humana from $246.00 to $415.00 and gave the stock a "sector perform" rating in a research note on Thursday, July 9th. Morgan Stanley raised shares of Humana from an "underweight" rating to an "equal weight" rating and increased their price target for the company from $249.00 to $370.00 in a report on Tuesday, August 4th. Truist Financial boosted their price objective on Humana from $320.00 to $415.00 and gave the stock a "hold" rating in a report on Tuesday, July 14th. Raymond James Financial downgraded Humana from an "outperform" rating to a "market perform" rating in a research report on Thursday, July 30th. Finally, HSBC lowered Humana to a "hold" rating in a research note on Thursday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has assigned a Sell rating to the company's stock. Based on data from MarketBeat.com, Humana presently has an average rating of "Moderate Buy" and an average price target of $415.57.

Humana Stock Performance

HUM opened at $406.23 on Wednesday. Humana has a 12-month low of $163.11 and a 12-month high of $428.88. The stock has a market cap of $48.78 billion, a price-to-earnings ratio of 38.43, a PEG ratio of 2.49 and a beta of 0.74. The business has a 50 day moving average of $386.26 and a 200-day moving average of $329.73. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.62.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, beating analysts' consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The business had revenue of $40.89 billion for the quarter, compared to analysts' expectations of $40.58 billion. During the same quarter in the prior year, the business earned $6.27 EPS. The firm's revenue for the quarter was up 26.2% on a year-over-year basis. On average, equities research analysts expect that Humana will post 9.01 earnings per share for the current year.

Institutional Investors Weigh In On Humana

A number of large investors have recently added to or reduced their stakes in HUM. BlackRock Inc. acquired a new stake in Humana during the second quarter worth about $4,138,160,000. Pzena Investment Management LLC acquired a new position in shares of Humana in the 2nd quarter valued at approximately $1,749,014,000. Legal & General Group Plc bought a new stake in shares of Humana during the 2nd quarter worth approximately $329,760,000. Barrow Hanley Mewhinney & Strauss LLC bought a new stake in shares of Humana during the 2nd quarter worth approximately $314,922,000. Finally, Bank of America Corp DE acquired a new stake in shares of Humana during the 2nd quarter worth approximately $279,490,000. Institutional investors and hedge funds own 92.38% of the company's stock.

Humana Company Profile

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana's insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.